Cargando…
930. Clinical Presentation, Treatment, and Outcomes for People with HIV with Histoplasmosis in Memphis, Tennessee
BACKGROUND: There is limited data on the presentation, treatment, and outcomes in persons with HIV (PWH) with histoplasmosis in the era of modern antiretroviral therapy (ART). We conducted a retrospective review of PWH presenting with histoplasmosis in Memphis, TN. METHODS: All cases of PWH with His...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776771/ http://dx.doi.org/10.1093/ofid/ofaa439.1116 |
_version_ | 1783630760082669568 |
---|---|
author | Cook, Julia C Lin, Corey Menzies, Barbara E Fuchs, Christian J Animalu, Chinelo N Mazumder, Shirin A Thomas-Gosain, Neena Summers, Nathan A |
author_facet | Cook, Julia C Lin, Corey Menzies, Barbara E Fuchs, Christian J Animalu, Chinelo N Mazumder, Shirin A Thomas-Gosain, Neena Summers, Nathan A |
author_sort | Cook, Julia C |
collection | PubMed |
description | BACKGROUND: There is limited data on the presentation, treatment, and outcomes in persons with HIV (PWH) with histoplasmosis in the era of modern antiretroviral therapy (ART). We conducted a retrospective review of PWH presenting with histoplasmosis in Memphis, TN. METHODS: All cases of PWH with Histoplasmosis diagnosed or treated between January 1, 2013 and December 31, 2019 at Regional One Health were identified. Cases captured in obsolete and inaccessible EMRs were excluded. Baseline demographics, presentation data, treatment, duration of treatment, and outcomes were abstracted by chart review. A pooled T-test was performed to compare outcomes between those receiving short (≤ 7 days) and longer courses (> 7 days) of amphotericin. RESULTS: Thirty-four participants were included, of which 30 (88%) were diagnosed in the hosptial. The mean age of participants was 41 years, 25 (73.5%) were male, and 31 (91%) were black. Median CD4 cell count and HIV viral load were 15 cells/µL, and 415,220 copies/mL, respectively. Median length of time between HIV diagnosis and presentation with histoplasmosis was 3.25 years. Common presenting symptoms included weight loss (21, 61.76%), gastrointestinal symptoms (22, 64.76%), and respiratory symptoms (19, 55.88%). Twenty-seven (79.41%) of participants met SIRS criteria on presentation, two required intensive care, and two participants met HLH criteria. The time between presentation and initiation of appropriate anti-fungal treatment was a median of 1.5 days. The majority of participants received amphotericin B as initial treatment (67.65%, N = 23). Twenty-five (60%) participants ultimately received amphotericin, 14 of whom received it for 7 days or less. The median duration of hospitalization was observed to be shorter among the group receiving 7 days or less of amphotericin (7 vs. 10.5 days), although not statistically significant. Overall 30 day mortality was 0%. CONCLUSION: This study describes a population of PWH presenting with histoplasmosis in Memphis, TN. Appropriate antifungal therapy was started quickly and patients did well whether they were treated with a short course (7 days or less) or long course of amphotericin. Further research on the duration of amphotericin B in this population is warranted. DISCLOSURES: All Authors: No reported disclosures |
format | Online Article Text |
id | pubmed-7776771 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-77767712021-01-07 930. Clinical Presentation, Treatment, and Outcomes for People with HIV with Histoplasmosis in Memphis, Tennessee Cook, Julia C Lin, Corey Menzies, Barbara E Fuchs, Christian J Animalu, Chinelo N Mazumder, Shirin A Thomas-Gosain, Neena Summers, Nathan A Open Forum Infect Dis Poster Abstracts BACKGROUND: There is limited data on the presentation, treatment, and outcomes in persons with HIV (PWH) with histoplasmosis in the era of modern antiretroviral therapy (ART). We conducted a retrospective review of PWH presenting with histoplasmosis in Memphis, TN. METHODS: All cases of PWH with Histoplasmosis diagnosed or treated between January 1, 2013 and December 31, 2019 at Regional One Health were identified. Cases captured in obsolete and inaccessible EMRs were excluded. Baseline demographics, presentation data, treatment, duration of treatment, and outcomes were abstracted by chart review. A pooled T-test was performed to compare outcomes between those receiving short (≤ 7 days) and longer courses (> 7 days) of amphotericin. RESULTS: Thirty-four participants were included, of which 30 (88%) were diagnosed in the hosptial. The mean age of participants was 41 years, 25 (73.5%) were male, and 31 (91%) were black. Median CD4 cell count and HIV viral load were 15 cells/µL, and 415,220 copies/mL, respectively. Median length of time between HIV diagnosis and presentation with histoplasmosis was 3.25 years. Common presenting symptoms included weight loss (21, 61.76%), gastrointestinal symptoms (22, 64.76%), and respiratory symptoms (19, 55.88%). Twenty-seven (79.41%) of participants met SIRS criteria on presentation, two required intensive care, and two participants met HLH criteria. The time between presentation and initiation of appropriate anti-fungal treatment was a median of 1.5 days. The majority of participants received amphotericin B as initial treatment (67.65%, N = 23). Twenty-five (60%) participants ultimately received amphotericin, 14 of whom received it for 7 days or less. The median duration of hospitalization was observed to be shorter among the group receiving 7 days or less of amphotericin (7 vs. 10.5 days), although not statistically significant. Overall 30 day mortality was 0%. CONCLUSION: This study describes a population of PWH presenting with histoplasmosis in Memphis, TN. Appropriate antifungal therapy was started quickly and patients did well whether they were treated with a short course (7 days or less) or long course of amphotericin. Further research on the duration of amphotericin B in this population is warranted. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7776771/ http://dx.doi.org/10.1093/ofid/ofaa439.1116 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Poster Abstracts Cook, Julia C Lin, Corey Menzies, Barbara E Fuchs, Christian J Animalu, Chinelo N Mazumder, Shirin A Thomas-Gosain, Neena Summers, Nathan A 930. Clinical Presentation, Treatment, and Outcomes for People with HIV with Histoplasmosis in Memphis, Tennessee |
title | 930. Clinical Presentation, Treatment, and Outcomes for People with HIV with Histoplasmosis in Memphis, Tennessee |
title_full | 930. Clinical Presentation, Treatment, and Outcomes for People with HIV with Histoplasmosis in Memphis, Tennessee |
title_fullStr | 930. Clinical Presentation, Treatment, and Outcomes for People with HIV with Histoplasmosis in Memphis, Tennessee |
title_full_unstemmed | 930. Clinical Presentation, Treatment, and Outcomes for People with HIV with Histoplasmosis in Memphis, Tennessee |
title_short | 930. Clinical Presentation, Treatment, and Outcomes for People with HIV with Histoplasmosis in Memphis, Tennessee |
title_sort | 930. clinical presentation, treatment, and outcomes for people with hiv with histoplasmosis in memphis, tennessee |
topic | Poster Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776771/ http://dx.doi.org/10.1093/ofid/ofaa439.1116 |
work_keys_str_mv | AT cookjuliac 930clinicalpresentationtreatmentandoutcomesforpeoplewithhivwithhistoplasmosisinmemphistennessee AT lincorey 930clinicalpresentationtreatmentandoutcomesforpeoplewithhivwithhistoplasmosisinmemphistennessee AT menziesbarbarae 930clinicalpresentationtreatmentandoutcomesforpeoplewithhivwithhistoplasmosisinmemphistennessee AT fuchschristianj 930clinicalpresentationtreatmentandoutcomesforpeoplewithhivwithhistoplasmosisinmemphistennessee AT animaluchinelon 930clinicalpresentationtreatmentandoutcomesforpeoplewithhivwithhistoplasmosisinmemphistennessee AT mazumdershirina 930clinicalpresentationtreatmentandoutcomesforpeoplewithhivwithhistoplasmosisinmemphistennessee AT thomasgosainneena 930clinicalpresentationtreatmentandoutcomesforpeoplewithhivwithhistoplasmosisinmemphistennessee AT summersnathana 930clinicalpresentationtreatmentandoutcomesforpeoplewithhivwithhistoplasmosisinmemphistennessee |